Secbutonitazene
Secbutonitazene[edit | edit source]
Secbutonitazene is a synthetic opioid analgesic that belongs to the benzimidazole class of compounds. It is structurally related to other nitazene derivatives, which are known for their potent opioid effects. Secbutonitazene has gained attention due to its high potency and potential for abuse, similar to other synthetic opioids.
Chemical Structure and Properties[edit | edit source]
Secbutonitazene is characterized by its benzimidazole core structure, which is a common feature among nitazene derivatives. The chemical structure of Secbutonitazene includes a sec-butyl group, which differentiates it from other related compounds. This structural modification contributes to its unique pharmacological profile.
The molecular formula of Secbutonitazene is C23H30N4O2, and it has a molecular weight of approximately 394.52 g/mol. The compound is typically synthesized in a laboratory setting and is not found naturally.
Pharmacology[edit | edit source]
Secbutonitazene acts as a potent agonist at the mu-opioid receptor, which is the primary target for opioid analgesics. Activation of these receptors results in analgesic effects, as well as the potential for euphoria, respiratory depression, and physical dependence. The potency of Secbutonitazene is reported to be significantly higher than that of morphine, making it a substance of concern in terms of overdose risk.
Medical Use and Regulation[edit | edit source]
Currently, Secbutonitazene does not have any approved medical uses. It is primarily encountered in the context of illicit drug use. Due to its high potency and potential for abuse, Secbutonitazene is subject to regulatory control in many jurisdictions. It is often classified as a controlled substance, and its distribution and use are heavily restricted.
Risks and Concerns[edit | edit source]
The primary risks associated with Secbutonitazene are related to its high potency and the potential for overdose. Like other potent opioids, it can cause severe respiratory depression, which can be fatal if not promptly treated. The risk of overdose is particularly high when Secbutonitazene is used in combination with other central nervous system depressants, such as alcohol or benzodiazepines.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
